Mazdutide
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
Innovent · Phase 2 · Completed · Enrollment 328
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| IBI362 high dose | Obesity or overweight | n/r | 24 | n/r | n/r |
| IBI362 low dose | Obesity or overweight | n/r | 24 | n/r | n/r |
| placebo | Obesity or overweight | n/r | 24 | n/r | n/r |
| IBI362 moderate dose | Obesity or overweight | n/r | 24 | n/r | n/r |
| IBI362 extra high dose | Obesity or overweight | n/r | 24 | n/r | n/r |